Healey lashes out at biotech firm over ‘unfair’ drug prices

BOSTON – Massachusetts Attorney General Maura Healey may go after Gilead Sciences over the price of its new hepatitis C treatment, Sovaldi, calling the $84,000 cost of a full treatment against the deadly disease potentially an illegal unfair trade practice. Healey referred to pricing for the drug as well as another hepatitis C treatment called Harvoni in speech Wednesday to members of the state's biotechnology industry, appealing to them for greater transparency in the way prices are set. She a

BOSTON – Massachusetts Attorney General Maura Healey may go after Gilead Sciences over the price of its new hepatitis C treatment, Sovaldi, calling the $84,000 cost of a full treatment against the deadly disease potentially an illegal unfair trade practice. Healey referred to pricing for the drug as well as another hepatitis C treatment called Harvoni in speech Wednesday to members of the state's biotechnology industry, appealing to them for greater transparency in the way prices are set. She a…